Learn about a clinical trials to evaluate a new investigational medicine that may help reduce seizures in adults.
Who can participate in this study?
QUALIFIED PARTICIPANTS MUST:
- Age between 18 and 75 years
- Currently receiving 1-3 allowable ASMs (Anti-Seizure Medications) with stable doses for at least 4 weeks
- Participant and/or caregiver self-reports at least countable generalized tonic-clonic seizures within the last 8 weeks